FDA vs CE for LED Therapy Devices — What Every International Buyer Needs to Know
FDA clearance and CE marking are not equivalent and do not substitute for each other. CE (EU MDR) is fundamentally a self-declaration model — the manufacturer declares conformity, with a Notified Body review for Class IIa and above. FDA is a premarket review model — for most therapeutic LED devices, the manufacturer submits a 510(k) and receives a clearance letter before selling in the US. The critical buyer distinction: “FDA Registered” ≠ “FDA Cleared” — registration is administrative; only a 510(k) clearance letter authorizes US marketing. Both systems share common ground in IEC 60601-1, ISO 10993, and IEC 62304.
Table of Contents
- 1. The Fundamental Difference
- 2. How Each System Classifies Devices
- 3. The Technical File
- 4. IEC 60601-1 as Common Ground
- 5. Labeling & Registration
- 6. Key Differences at a Glance
- 7. Common Misconceptions
- 8. Common Questions
For LED therapy device buyers sourcing from international manufacturers, one of the most common sources of confusion is the relationship between FDA clearance (US) and CE marking (EU). Both are forms of market authorization, and both are required or expected in their markets — but they are not equivalent, they do not substitute for each other, and the path to one does not automatically deliver the other.
1. The Fundamental Difference: Premarket Review vs. Self-Declaration
CE marking (EU MDR): the manufacturer compiles a technical file, performs a conformity assessment (self-assessment for Class I, Notified Body review for Class IIa+), and issues a Declaration of Conformity. The Notified Body doesn’t “approve” the product — it assesses whether the QMS and technical file support the claims. CE is a self-declaration model with a third-party check for higher-risk devices.
FDA (US): for most therapeutic LED devices, the manufacturer submits a 510(k) Premarket Notification and receives a clearance letter before marketing. The FDA reviews the file — comparing the new device to a predicate — and issues a clearance decision. FDA is a premarket review model. Both systems require a QMS and adverse-event reporting, but neither implies the other.
2. How Each System Classifies Devices
United States — FDA Classification
Most LED therapy devices for aesthetic/wellness use fall into Class II under the 510(k) pathway. Relevant product codes: OIF (LED lamp for aesthetic use) and OHR (LED phototherapy for periorbital rejuvenation). The 510(k) route requires demonstrating substantial equivalence to a legally marketed predicate device.
European Union — EU MDR Classification
Under EU MDR 2017/745 (fully replacing MDD 93/42/EEC on May 26, 2021), LED therapy devices are typically Class IIa under Rule 9 (energy administration) or Rule 10 (physiological monitoring). Classification is driven by the intended purpose declared in the IFU and marketing — aesthetic (non-medical) claims vs medical treatment claims move the class.
3. The Technical File
FDA 510(k) Technical Summary
Device description → substantial-equivalence discussion → performance data (IEC 60601-1, IEC 60601-1-2, clinical performance) → biocompatibility (ISO 10993) → software documentation (IEC 62304) → 510(k) summary. Timeline: 90-day target (3–6 months realistic).
EU MDR Technical File
More extensive: device description → design & manufacturing info → GSPR (23 chapters) → benefit-risk + clinical evaluation (ISO 14971, ISO 14155/CER) → PMS plan + PSUR → labeling (UDI, EUDAMED) → DoC + EU Authorized Representative. Class IIa requires Notified Body review (4–9 months).
4. IEC 60601-1 as Common Ground
| Test | Standard | FDA | CE |
|---|---|---|---|
| Electrical safety | IEC 60601-1 | Required (510(k)) | Required (GSPR) |
| EMC | IEC 60601-1-2 | Required | Required |
| Biocompatibility | ISO 10993 | Required | Required |
| Software | IEC 62304 | Required if present | Required if present |
| Usability | IEC 62366-1 | Recommended | Recommended / required |
Key point for buyers: an IEC 60601-1 report is required for both FDA and CE — a manufacturer claiming FDA clearance who can’t produce one should raise immediate red flags.
5. Labeling & Registration
FDA: annual establishment registration (FURLS), device listing, UDI + GUDID submission, and MDR adverse-event reporting (30 days / 5 days for public-health threats).
EU MDR: CE label, EU Authorized Representative (mandatory for non-EU manufacturers), EUDAMED registration, UDI-DI/PI, PSUR (every 2 years for Class IIa+), and vigilance reporting (15 days / 2 days).
6. Key Differences at a Glance
| Aspect | FDA (US) | CE (EU) |
|---|---|---|
| Legal basis | FD&C Act | EU MDR 2017/745 |
| Classification | Class I, II, III | Class I, IIa, IIb, III |
| Pathway | 510(k) Premarket Notification | Notified Body review (IIa+) |
| Substantial equivalence | Required | N/A — GSPR compliance |
| QMS | 21 CFR Part 820 / ISO 13485 | ISO 13485 (required) |
| Adverse-event reporting | 30 days / 5 days | 15 days / 2 days |
| Timeline | 3–6 months | 4–9 months (IIa) |
| Local agent | US Agent (foreign mfr) | EU Authorized Representative |
7. Common Misconceptions
- “CE and FDA are equivalent.” They are not, and dual market access requires dual compliance.
- “FDA Registered = FDA Cleared.” Registration is administrative; only a 510(k) clearance letter authorizes US marketing. This is the single most important buyer distinction.
- “CE is a product certification like UL.” CE is a manufacturer’s declaration of conformity — the Notified Body reviews the file but the manufacturer applies the mark.
- “A test report = compliance.” A report documents one sample passing one test; compliance needs the report + QMS + complete technical file + ongoing post-market surveillance.
8. Common Questions
Q1: Can one regulatory submission cover both US and EU?
No — but the technical documentation overlaps significantly (IEC 60601-1, ISO 10993, IEC 62304). A file designed for both from the start reduces dual-submission effort. Use a specialist experienced in both.
Q2: What’s the minimum QMS for both?
ISO 13485:2016 is the foundation (required for CE, accepted as a basis for FDA’s 21 CFR Part 820). FDA additionally requires establishment registration and listing.
Q3: A manufacturer claims “FDA Cleared and CE Marked” — what should I ask for?
(1) FDA 510(k) clearance letter (verify the number on the FDA database), (2) CE certificate with the Notified Body’s 4-digit number (verify on NANDO), (3) current ISO 13485 certificate, and (4) the signed Declaration of Conformity. If any is missing or inconsistent, treat the claim as unverified.
Source Devices with Verifiable FDA & CE Status
This article reflects the perspective of an LED therapy OEM manufacturer that maintains both FDA 510(k) clearance and EU MDR CE marking across its product range. Regulatory claims should always be verifiable — not stated. (See also our CE testing guide and RoHS compliance guide.)
Explore OEM & ODM solutions · View our product lineup · Request regulatory documentation
Regulatory pathways, classification rules, and documentation requirements reflect current FDA and EU MDR regulations as of 2024. Requirements are subject to change — always verify with a qualified regulatory affairs specialist for your specific device and target markets.